Birmingham-Black Country-Atrial Fibrillation registry
Initiatives
-
Patients with and without AF. Blood based biomarkers and ECG markers were compared between the two groups of patients. The blood based biomarker analysis using a novel proteomics chip technique demonstrated that BNP and a novel biomarker, fibroblast growth factor 23 (FGF-23) were increased in AF patients and were also independently predictive of AF.
- Start Year
- 2014
- End Year
- 2016
- Funding
- University of Birmingham and The European Network for Translational Research in Atrial Fibrillation (EUTRAF)
| Investigators | Contacts |
|---|---|
|
Design
- Study design
- Patients' cohort
Marker Paper
Chua, W., Purmah, Y., Cardoso, V. R., Gkoutos, G. V., Tull, S. P., Neculau, G., Thomas, M. R., Kotecha, D., Lip, G., Kirchhof, P., & Fabritz, L. (2019). Data-driven discovery and validation of circulating blood-based biomarkers associated with prevalent atrial fibrillation. European heart journal, 40(16), 1268–1276. https://doi.org/10.1093/eurheartj/ehy815
PUBMED 30615112
Recruitment
- Sources of Recruitment
-
- Individuals
Number of participants
- Number of participants
- 800
- Number of participants with biosamples
Access
Availability of data and biosamples
| Data | |
| Biosamples | |
| Other |